The Dean's Office and Weill Cornell Medicine Enterprise Innovation proudly present:
Fifth Annual Symposium on Entrepreneurship and Academic Drug Development
This symposium is designed for faculty, trainees, and students interested in advancing their research from the lab to the clinic.
Learn about business development resources available at the Office of BioPharma Alliances & Research Collaborations, Center for Technology Licensing at Weill Cornell Medicine, BioVenture eLabs, and more.
A maximum of 100 individuals will be permitted to attend in person.
Reception to follow, 5:30 - 6:00 p.m.
Chief Executive Officer, Kallyope
"Harnessing Innovation for the Discovery of New Therapeutics in Pharma and Biotech"
Nancy A. Thornberry is founding CEO at Kallyope, a biotechnology company headquartered in NYC focused on the gut-brain axis. She was formerly Senior Vice President and Franchise Head, Diabetes and Endocrinology, for Merck & Co. Inc. In this role, she led discovery and clinical research in diabetes, osteoporosis, fertility and contraception. Prior to her role as Franchise Head, Nancy initiated and led Merck’s dipeptidyl peptidase 4 (DPP-4) project, which resulted in the discovery of JANUVIA® for the treatment of Type 2 diabetes.
Featured Speakers: Weill Cornell Medicine Faculty
Juan Cubillos-Ruiz, PhD
Associate Professor of Microbiology and Immunology in Obstetrics and Gynecology
William J. Ledger, M.D., Distinguished Associate Professor for Infection and Immunology in Obstetrics and Gynecology
"Pharmacological Control of ER Stress Sensors in Tumors: A New Approach to Cancer Immunotherapy"
John P. Leonard, MD
Senior Associate Dean for Innovation and Initiatives
Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
"Update on Weill Cornell Medicine Enterprise Innovation"
Monday, November 8 at 4:00pm to 5:30pm
1300 York Ave., New York NY 10065